Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic Patients

NCT05538546 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-09-14

No results posted yet for this study

Summary

Patients meet Baveno VI criteria (with a liver stiffness \<20kPa and with a platelet count \>150,000 are considered to have very low risk of having varices requiring treatment, but whether these patients can be followed up by repetition of this criteria lacks sufficient evidence. This study aimed to assess the value of Baveno VI criteria for following up and monitoring of varices needing treatment in patients with compensated cirrhosis.

Conditions

  • Cirrhosis
  • Varices
  • Non-invasive Evaluation

Interventions

DIAGNOSTIC_TEST

Complete blood count

Complete blood count will be conducted at 12th month and 24th month from baseline.

DIAGNOSTIC_TEST

Transient elastrography

Transient elastrography, and endoscopy will be conducted at 12th month and 24th month from baseline.

DIAGNOSTIC_TEST

Endoscopy

Endoscopy will be conducted at 12th month and 24th month from baseline.

Sponsors & Collaborators

  • Fifth Hospital of Shijiazhuang City

    collaborator OTHER
  • The Sixth Hospital of Qingdao

    collaborator UNKNOWN
  • The Sixth Hospital of Dalian

    collaborator UNKNOWN
  • The Third People's Hospital of Taiyuan

    collaborator OTHER
  • The Fourth People's Hospital of Qinghai Province

    collaborator OTHER
  • Affiliated Hospital of Nanjing University of Chinese Medicine

    collaborator OTHER
  • The Fifth People's Hospital of Wuxi Affiliated Hospital of Jiangnan University

    collaborator UNKNOWN
  • Beilun Hospital of Chinese Medicine

    collaborator UNKNOWN
  • Gansu Wuwei Tumor Hospital

    collaborator OTHER
  • The Affiliated Hospital of Xuzhou Medical University

    collaborator OTHER
  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER
  • The Third People's Hospital of Linfen City

    collaborator UNKNOWN
  • The First Affiliated Hospital of Xian Jiaotong University

    collaborator UNKNOWN
  • The Third Affiliated Hospital of Hebei Medical University

    collaborator UNKNOWN
  • The First Affiliated Hospital of Anhui Medical University

    collaborator OTHER
  • Liuzhou Workers' Hospital

    collaborator OTHER_GOV
  • The First People's Hospital of Taicang

    collaborator UNKNOWN
  • Xinjiang Hospital of Chinese Medicine

    collaborator UNKNOWN
  • Taizhou People's Hospital

    collaborator UNKNOWN
  • Shenzhen Third People's Hospital

    collaborator OTHER
  • Huashan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2022-12-31
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05538546 on ClinicalTrials.gov